Future Prospects, Approaches, and the Government’s Role in the Development of a Hepatitis C Virus Vaccine
Pathogens · 2023
DOI: 10.3390/pathogens13010038 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Pathogens, 2023. Verfasst von Ashraf A Tabll und 8 weiteren Autor:innen. Beteiligte Einrichtung: Microbial Biotechnology Department, Biotechnology Research Institute, National Research Centre, Cairo 12622, Egypt. Hauptthemen laut MEDLINE: Hepatitis C, Hepacivirus, Vaccine Development, Viral Hepatitis Vaccines. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 99 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Croatian Ministry of Science, Croatian Ministry of Science and Education.
Abstract (Originalsprache)
Developing a safe and effective vaccine against the hepatitis C virus (HCV) remains a top priority for global health. Despite recent advances in antiviral therapies, the high cost and limited accessibility of these treatments impede their widespread application, particularly in resource-limited settings. Therefore, the development of the HCV vaccine remains a necessity. This review article analyzes the current technologies, future prospects, strategies, HCV genomic targets, and the governmental role in HCV vaccine development. We discuss the current epidemiological landscape of HCV infection and the potential of HCV structural and non-structural protein antigens as vaccine targets. In addition, the involvement of government agencies and policymakers in supporting and facilitating the development of HCV vaccines is emphasized. We explore how vaccine development regulatory channels and frameworks affect research goals, funding, and public health policy. The significance of international and public-private partnerships in accelerating the development of an HCV vaccine is examined. Finally, the future directions for developing an HCV vaccine are discussed. In conclusion, the review highlights the urgent need for a preventive vaccine to fight the global HCV disease and the significance of collaborative efforts between scientists, politicians, and public health organizations to reach this important public health goal.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Microbial Biotechnology Department, Biotechnology Research Institute, National Research Centre, Cairo 12622, Egypt.
- Egypt Centre for Research and Regenerative Medicine (ECRRM), Cairo 11517, Egypt.
- Special Infectious Agents Unit, King Fahd Medical Research Center, King Abdulaziz University, Jeddah 21589, Saudi Arabia.
- Department of Medical Laboratory Technology, Faculty of Applied Medical Sciences, King Abdulaziz University, Jeddah 21589, Saudi Arabia.
- Molecular Biology Department, Biotechnology Research Institute, National Research Centre, Cairo 12622, Egypt.
- Faculty of Dental Medicine and Health Osijek, Josip Juraj Strossmayer University of Osijek, 31000 Osijek, Croatia.
ORCID-Profile: Sayed S Sohrab, Ahmed A Ali, Martina Smolic
Förderung
- Croatian Ministry of Science
- Croatian Ministry of Science and Education
Zitieren
APA
Tabll, A. A., Sohrab, S. S., Ali, A. A., Petrovic, A., Steiner Srdarevic, S., Siber, S., Glasnovic, M., Smolic, R., & Smolic, M. (2023). Future Prospects, Approaches, and the Government’s Role in the Development of a Hepatitis C Virus Vaccine. Pathogens. https://doi.org/10.3390/pathogens13010038
Vancouver
Tabll AA, Sohrab SS, Ali AA, Petrovic A, Steiner Srdarevic S, Siber S, et al. Future Prospects, Approaches, and the Government’s Role in the Development of a Hepatitis C Virus Vaccine. Pathogens. 2023. doi:10.3390/pathogens13010038
BibTeX
@article{Tabll2023,
author = {Tabll, Ashraf A and Sohrab, Sayed S and Ali, Ahmed A and Petrovic, Ana and Steiner Srdarevic, Sabina and Siber, Stjepan and Glasnovic, Marija and Smolic, Robert and Smolic, Martina},
title = {Future Prospects, Approaches, and the Government’s Role in the Development of a Hepatitis C Virus Vaccine},
journal = {Pathogens},
year = {2023},
doi = {10.3390/pathogens13010038}
}
EUVIMED